The Food and Drug Administration (FDA) inspected CSL Plasma, Inc. in Douglas on March 5, reviewing blood and blood product operations, according to information posted on the FDA’s website.
The official report found that CSL Plasma, Inc. was not required to make any changes to its management operations.
The FDA regularly inspects facilities nationwide to verify workplaces and products comply with FDA-regulated laws and public health regulations. Inspection outcomes are made available to the public.
The FDA’s website states the agency is primarily responsible for overseeing the production and distribution of human and animal drugs, biological products, medical devices and tobacco products for safety and quality.
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.
